| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/29/2011 | EP1883645B1 Derivatives of 4-or 5-aminosalicylic acid |
| 06/29/2011 | EP1849774B1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME |
| 06/29/2011 | EP1846407B1 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitor of renin for the treatment of hypertension. |
| 06/29/2011 | EP1799825B1 Aptamer regulated nucleic acids and uses thereof |
| 06/29/2011 | EP1767536B1 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof |
| 06/29/2011 | EP1755606B2 Quinazolinone derivatives useful as vanilloid antagonists |
| 06/29/2011 | EP1737493B1 Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumor cell growth |
| 06/29/2011 | EP1730142B1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
| 06/29/2011 | EP1727786B1 Acid addition salts of 5-aminolevulinic acid or its derivatives |
| 06/29/2011 | EP1585502B1 Fast-disintegrating solid dosage forms being not friable and comprising pullulan |
| 06/29/2011 | EP1499313B1 Heterocyclic derivatives as opioid receptor modulators |
| 06/29/2011 | EP1482930B1 Peptide deformylase inhibitors |
| 06/29/2011 | EP1435786B1 Pesticidal formulations |
| 06/29/2011 | EP1414314B1 Composition for lowering blood cholesterol |
| 06/29/2011 | EP1379225B1 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 06/29/2011 | EP1326834B1 2-substituted heterocyclic compounds |
| 06/29/2011 | EP1322315B1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 06/29/2011 | EP1233958B1 Inhibitors of histone deacetylase |
| 06/29/2011 | EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands |
| 06/29/2011 | EP1124567B2 Buffered compositions for dialysis |
| 06/29/2011 | EP1061915B1 Pharmaceutical formulations of taxanes |
| 06/29/2011 | EP0923932B1 Composition containing antitumor agent |
| 06/29/2011 | CN1989963B Pharmaceutical compositions |
| 06/29/2011 | CN1988897B Use of balsalazide in preparing medicine for radiation induced enteritis |
| 06/29/2011 | CN1972932B Compounds for treating dyslipidemia |
| 06/29/2011 | CN1942183B Isosorbide-containing jelly preparation |
| 06/29/2011 | CN1894251B Crystalline forms of (6R)-l-erythro-tetrahydrobiopterin dihydrochloride |
| 06/29/2011 | CN1850112B Polyethylene glycol electrolyte oral solution |
| 06/29/2011 | CN1812974B N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 06/29/2011 | CN1812794B Medicinal composition in solution form |
| 06/29/2011 | CN1806827B Chinese medicinal composition, its preparation process and quality control method |
| 06/29/2011 | CN102112486A Hepatitis c virus inhibitors |
| 06/29/2011 | CN102112484A Triterpene saponins, methods of synthesis, and uses thereof |
| 06/29/2011 | CN102112483A Solid forms of (2s, 3r, 4r, 5s, 6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3, 4, 5-triol and methods of their use |
| 06/29/2011 | CN102112481A Process for producing carnosol from carnosic acid using hydrogen peroxide or peracids |
| 06/29/2011 | CN102112480A 1, 6-dihydro-2H-3-oxa-6-aza-as-indacene compounds |
| 06/29/2011 | CN102112479A Buprenorphine analogs |
| 06/29/2011 | CN102112478A 5H-pyrr0l0 [2, 3-B] pyrazine derivatives for kinase modulation, and indications therefor |
| 06/29/2011 | CN102112477A 6-(c2-6alkylseleno) purines and methods for treating neural measles viral infection therewith |
| 06/29/2011 | CN102112476A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2011 | CN102112475A Imidazopyridine and related analogs as sirtuin modulators |
| 06/29/2011 | CN102112474A Quinuclidine carbonate derivatives and medicinal composition thereof |
| 06/29/2011 | CN102112473A Pyrrolidinyl-alkyl-amide derivatives, their preparation and their therapeutic application as ccr3 receptor ligands |
| 06/29/2011 | CN102112472A 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 06/29/2011 | CN102112471A 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 06/29/2011 | CN102112469A Silent desensitizers of neuronal nAChR and methods of use thereof |
| 06/29/2011 | CN102112468A New compounds |
| 06/29/2011 | CN102112467A Compounds and compositions as kinase inhibitors |
| 06/29/2011 | CN102112466A (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 06/29/2011 | CN102112465A Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| 06/29/2011 | CN102112463A 5-substituted isoindoline compounds |
| 06/29/2011 | CN102112462A Aminopropylidene derivative |
| 06/29/2011 | CN102112453A Novel potassium channel blockers and uses thereof |
| 06/29/2011 | CN102112451A Diazepan and piperazine derivatives modulators of chemokine receptors |
| 06/29/2011 | CN102112450A 5-alkynyl-pyrimidines |
| 06/29/2011 | CN102112449A Phenyl or pyridinyl substituted indazoles derivatives |
| 06/29/2011 | CN102112448A DAA-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
| 06/29/2011 | CN102112447A HIV integrase inhibitors from pyridoxine |
| 06/29/2011 | CN102112446A Phenanthrenone compounds, compositions and methods |
| 06/29/2011 | CN102112445A Hydroxyphenylsulfonamides as antiapoptotic Bcl inhibitors |
| 06/29/2011 | CN102112441A Use of indole derivatives as NURR-1 activators for treating parkinson's disease |
| 06/29/2011 | CN102112440A Heterocyclic compound |
| 06/29/2011 | CN102112436A Novel and efficient method for synthesis of amino acid |
| 06/29/2011 | CN102112142A Extraction method for increasing liquiritigenin content in glycyrrhizae radix et rhizoma or glycyrrhizae radix extract |
| 06/29/2011 | CN102112137A Film-forming liquid formulations for drug release to hair and scalp |
| 06/29/2011 | CN102112136A Composition for inhibiting expression of target gene |
| 06/29/2011 | CN102112135A Vaccine composition containing synthetic adjuvant |
| 06/29/2011 | CN102112134A Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity |
| 06/29/2011 | CN102112133A Pharmaceutical uses of lanosta-8, 24-dien-3-ols |
| 06/29/2011 | CN102112132A Triterpenoid-based compound used as a virus inhibitor |
| 06/29/2011 | CN102112131A Methods of treating thalassemia |
| 06/29/2011 | CN102112130A Pyrazine derivatives as epithelial sodium channel blockers |
| 06/29/2011 | CN102112129A Thiazole compounds, and compositions and methods using same |
| 06/29/2011 | CN102112128A Pharmaceutical composition containing 1, 2-dithiolthione derivative for preventing or treating disease caused by overexpression of LXR-alpha |
| 06/29/2011 | CN102112127A Escalating dosing regimen for effecting weight loss and treating obesity |
| 06/29/2011 | CN102112126A Low dose topiramate/phentermine compostion and methods of use thereof |
| 06/29/2011 | CN102112125A Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 06/29/2011 | CN102112124A 保护正常细胞 Protect normal cells |
| 06/29/2011 | CN102112123A Conjugated suramin amino compounds for medical conditions |
| 06/29/2011 | CN102112122A Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof |
| 06/29/2011 | CN102112121A Methods, compositions, and kits for treating pain and pruritis |
| 06/29/2011 | CN102112120A Composition and method for treatment of MRSA |
| 06/29/2011 | CN102112119A Diaryl hepatonoid-based compound useful as virus inhibitor |
| 06/29/2011 | CN102112118A Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates |
| 06/29/2011 | CN102112116A 递送颗粒 Delivery particle |
| 06/29/2011 | CN102112115A Modified release ramipril compositions and uses thereof |
| 06/29/2011 | CN102112114A Use of sucralose as a granulating agent |
| 06/29/2011 | CN102112108A Aqueous pharmaceutical formulation |
| 06/29/2011 | CN102112107A Controlled release copolymer formulation with improved release kinetics |
| 06/29/2011 | CN102111999A Methods for controlling qoi-resistant fungal pathogens |
| 06/29/2011 | CN102111998A Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 06/29/2011 | CN102108372A Preparation method and application of beta-glucan |
| 06/29/2011 | CN102108355A Multi-epitope artificial antigen of plasmodium falciparum and application thereof |
| 06/29/2011 | CN102108092A 23-hydroxy betulinic acid derivative as well as preparation method and application thereof |
| 06/29/2011 | CN102108090A Dihydroiso-coumarin glucoside compounds and preparation method and application thereof |
| 06/29/2011 | CN102108083A Polycyclic benzopyrone compounds and preparation method and application thereof |
| 06/29/2011 | CN102108081A Novel crystal form of Iloperidone and preparation method thereof |
| 06/29/2011 | CN102108079A 4-anilino quinazoline derivatives serving as tyrosine kinase inhibitors |
| 06/29/2011 | CN102108078A 1,4-substituted phthalazine compound and preparation method and applications thereof |
| 06/29/2011 | CN102108075A Method for synthesizing novel derivatives from gibberellane GA3 and use thereof |